share_log

6-K: Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive Chmp Opinion to Expand Approval to All Adult Patients with Primary Advanced or Recurrent Endometrial Cancer

SEC ·  Dec 16 21:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more